soul trial oral semaglutide cardiovascular outcomes results 2024 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Frontiers | Effects of subcutaneous

All other data supporting the findings of this study are available from the corresponding authors on reasonable request

However, using GLP-1 agonists for minor weight loss or body sculpting when one is already at a healthy weight is not only medically inappropriate but also carries significant health risks without the offsetting medical benefits

In men, Tongkat Ali may help activate hormones that stimulate the testicles to produce testosterone

Topical research's dose-response curves do not transfer to injectable use

10.1038/nature09944 Nature 7 AtashrazmF.HammondD.PereraG.Dobson-StoneC.MuellerN.PickfordR.et al (2018)

Detailed Guide on Vitamin C Serum 3